|
Volumn 59, Issue 6, 2007, Pages 778-784
|
Amantadine as an additive treatment in patients suffering from drug-resistant unipolar depression
|
Author keywords
Amantadine; Clinical and pharmacokinetic studies; Humans; Imipramine; Therapy resistant unipolar depression
|
Indexed keywords
AMANTADINE;
AMANTIX;
ANTIDEPRESSANT AGENT;
BENZODIAZEPINE DERIVATIVE;
CARBAMAZEPINE;
DESIPRAMINE;
IMIPRAMINE;
LITHIUM;
MOOD STABILIZER;
NEUROLEPTIC AGENT;
SEROTONIN UPTAKE INHIBITOR;
TRICYCLIC ANTIDEPRESSANT AGENT;
VENLAFAXINE;
ADD ON THERAPY;
ADULT;
ARTICLE;
BLOOD PRESSURE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
COMBINATION CHEMOTHERAPY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS;
DRUG BLOOD LEVEL;
DRUG DOSE REGIMEN;
DRUG EFFICACY;
DRUG POTENTIATION;
FEMALE;
HAMILTON SCALE;
HUMAN;
MAJOR DEPRESSION;
MALE;
MONOTHERAPY;
SIDE EFFECT;
TREATMENT DURATION;
TREATMENT OUTCOME;
XEROSTOMIA;
|
EID: 42549171085
PISSN: 22995684
EISSN: 22995684
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (51)
|
References (31)
|